Systematic evaluation and optimization of protein extraction parameters in diagnostic FFPE specimens.
Antigen retrieval
Biomarker
Clinical proteomics
Crosslinking reversal
Formalin-fixed paraffin-embedded tissue
Protein analysis
Protein extraction
Journal
Clinical proteomics
ISSN: 1542-6416
Titre abrégé: Clin Proteomics
Pays: England
ID NLM: 101184586
Informations de publication
Date de publication:
02 May 2022
02 May 2022
Historique:
received:
04
05
2021
accepted:
04
04
2022
entrez:
3
5
2022
pubmed:
4
5
2022
medline:
4
5
2022
Statut:
epublish
Résumé
Formalin-fixed paraffin-embedded (FFPE) tissue is the standard material for diagnostic pathology but poses relevant hurdles to accurate protein extraction due to cross-linking and chemical alterations. While numerous extraction protocols and chemicals have been described, systematic comparative analyses are limited. Various parameters were thus investigated in their qualitative and quantitative effects on protein extraction (PE) efficacy. Special emphasis was put on preservation of membrane proteins (MP) as key subgroup of functionally relevant proteins. Using the example of urothelial carcinoma, FFPE tissue sections were subjected to various deparaffinization, protein extraction and antigen retrieval protocols and buffers as well as different extraction techniques. Performance was measured by protein concentration and western blot analysis of cellular compartment markers as well as liquid chromatography-coupled mass spectrometry (LC-MS). Commercially available extraction buffers showed reduced extraction of MPs and came at considerably increased costs. On-slide extraction did not improve PE whereas several other preanalytical steps could be simplified. Systematic variation of temperature and exposure duration demonstrated a quantitatively relevant corridor of optimal antigen retrieval. Preanalytical protein extraction can be optimized at various levels to improve unbiased protein extraction and to reduce time and costs.
Identifiants
pubmed: 35501693
doi: 10.1186/s12014-022-09346-0
pii: 10.1186/s12014-022-09346-0
pmc: PMC9063121
doi:
Types de publication
Journal Article
Langues
eng
Pagination
10Subventions
Organisme : Else Kröner-Fresenius-Stiftung
ID : 2018_A84
Informations de copyright
© 2022. The Author(s).
Références
Histopathology. 2006 Oct;49(4):411-24
pubmed: 16978205
Int J Proteomics. 2016;2016:4324987
pubmed: 27660725
Anal Chim Acta. 2013 Sep 24;796:48-54
pubmed: 24016582
Clin Proteomics. 2018 Mar 06;15:11
pubmed: 29527141
Clin Proteomics. 2014 Jul 08;11(1):28
pubmed: 25097466
Curr Protoc Mol Biol. 2010 Apr;Chapter 10:Unit 10.27.1-12
pubmed: 20373500
Prog Histochem Cytochem. 2007;41(3):141-200
pubmed: 17197287
Breast Cancer Res Treat. 2016 Jan;155(1):25-35
pubmed: 26661092
Nucleic Acids Res. 2019 Jan 8;47(D1):D442-D450
pubmed: 30395289
J Histochem Cytochem. 2009 Sep;57(9):849-60
pubmed: 19471015
Nat Methods. 2009 May;6(5):359-62
pubmed: 19377485
Lab Invest. 2005 Nov;85(11):1416-28
pubmed: 16127423
Biotechniques. 2016 May 01;60(5):229-38
pubmed: 27177815
Clin Proteomics. 2014 Feb 01;11(1):4
pubmed: 24484752
Fundam Clin Pharmacol. 2008 Feb;22(1):1-18
pubmed: 18251718
J Biol Chem. 2015 Oct 30;290(44):26404-11
pubmed: 26354429
J Pathol. 2009 Mar;217(4):497-506
pubmed: 19156775
Expert Rev Proteomics. 2013 Aug;10(4):389-400
pubmed: 23992421
Biochim Biophys Acta. 2015 Jun;1854(6):559-80
pubmed: 25315853
Mol Biotechnol. 2013 Nov;55(3):217-26
pubmed: 23709336
MethodsX. 2014 Aug 08;1:90-5
pubmed: 26150940
Mol Cell Proteomics. 2002 Apr;1(4):304-13
pubmed: 12096112
Proteomics. 2011 Jun;11(12):2555-9
pubmed: 21591256
Proteomics Clin Appl. 2008 Oct;2(10-11):1539-47
pubmed: 21136801
Proteomics. 2015 Nov;15(21):3744-53
pubmed: 26306679
Int J Mol Sci. 2015 Feb 05;16(2):3537-63
pubmed: 25664860
Curr Protoc Mol Biol. 2010 Apr;Chapter 10:Unit 10.26.1-7
pubmed: 20373499
PLoS One. 2015 Nov 18;10(11):e0142650
pubmed: 26580073
Proteomics. 2017 Oct;17(20):
pubmed: 28271630
Nat Protoc. 2007;2(8):1896-906
pubmed: 17703201
PLoS One. 2010 Dec 08;5(12):e14253
pubmed: 21170380
Methods Mol Biol. 2019;1987:51-64
pubmed: 31028673
Trends Pharmacol Sci. 2014 Jan;35(1):41-50
pubmed: 24361003
Proteomics. 2009 Aug;9(15):3815-23
pubmed: 19637237
F1000Res. 2013 Dec 13;2:272
pubmed: 24741437
Q Rev Biophys. 1975 May;8(2):185-235
pubmed: 1103214
J Biol Chem. 2004 Feb 20;279(8):6235-43
pubmed: 14638685
J Proteome Res. 2011 Dec 2;10(12):5536-46
pubmed: 22029901
Nucleic Acids Res. 2008 Jan;36(Database issue):D230-3
pubmed: 17986452
Proteomics. 2012 Apr;12(7):1045-58
pubmed: 22318899
Anal Biochem. 2016 Aug 15;507:71-3
pubmed: 27287960
J Pathol. 2020 May;251(1):100-112
pubmed: 32154592
Proteomics Clin Appl. 2013 Apr;7(3-4):264-72
pubmed: 23339100